Facial Lipoatrophy: Appearances Are Not Deceiving

References 

1. Bernasconi E, Boubaker K, Junghans C, Flepp M, Furer H, Haensel A, et al. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs. Journal of Acquired Immune Deficiency Syndromes. 2002;31:50
2. Blanch J, Rousaud A, Martinez E, De Lazzari E, Milinkovic A, Peri J, et al. Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1. Clinical Infectious Diseases. 2004;38:1464–1470
3. Blanch J, Rousaud A, Martinez E, De Lazzari E, Peri J, Milinkovic A, et al. Impact of lipodystrophy on the quality of life of HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes. 2002;31:404
4. Bourgoyne R, Collins E, Wagner C, Abbey S, Halman M, Nur M, et al. The relationship between lipodystrophy-associated bodily changes and measures of quality of life and mental health for HIV-positive adults. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care, and Rehabilitation. 2005;14:981–990
5. Brazilian Ministry of Health. Targets and commitments made by the member-states at the United Nations General Assembly Special Session on HIV/AIDS: Brazilian response 2005-2007 country progress report. Brazil: Health Surveillance Secretariat, National STD and AIDS Programme; 2008;
6. Brink PJ, Wood MJ. Advanced design in nursing research. 2nd ed.. Thousand Oaks, CA: Sage Publications; 1998;
7. Carr A. Treatment strategies for HIV lipodystrophy. Current Opinion in HIV and AIDS. 2008;2:332–338
   • CrossRef
8. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. The AIDS Reader. 2000;10:546–550
   • MEDLINE
9. Castilho EA, Kalil J. Ethics and medical research: Principles, guidelines, and regulations. Revista da Sociedade Brasileira de Medicina Tropical. 2005;38:344–347
   • MEDLINE
   • CrossRef
10. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D: A:D) Study. Diabetes Care. 2008;31:1224–1229
    • CrossRef
11. Doward LC, Dietz B, Wilburn J, McKenna SP, Bhor M, Rajagopalan R. Impact of lipoatrophy on patient-reported outcomes in antiretroviral experienced patients. AIDS Reader. 2008;18:242
12. Duran S, Saves M, Spire B, Cailleton V, Sobel A, Carrieri P, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS. 2001;15:2441–2444
    • MEDLINE
    • CrossRef
13. Green ML. Evaluation and management of dyslipidemia in patients with HIV infection. Journal of General Internal Medicine. 2002;17:797–810
    • MEDLINE
    • CrossRef
14. Guaraldi G, Murri R, Orlando G, Orlandi E, Sterrantino G, Borderi M, et al. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials. 2003;4:99–106
    • MEDLINE
    • CrossRef
15. Huang JS, Lee D, Becerra R, Santos R, Barber E, Mathews C. Body image in men with HIV. AIDS Patient Care and STDs. 2006;20:668–677
    • MEDLINE
    • CrossRef
16. Joint United Nations Programme on HIV/AIDS. (2008). 2008 Report on the global AIDS epidemic. UNAIDS. Retrieved December 10, 2008, from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/
17. Jones D. Approaches to treatment of HIV facial lipoatrophy. Skin Therapy Letter. 2005;10:5–7
    • MEDLINE
18. Kotler DP. HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: Etiology and pathogenesis. The AIDS Reader. 2003;13:S5–S9
    • MEDLINE
19. Kotler DP. HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes. 2008;49:79–85
20. Martinez E, Garcia-Viejo MA, Blanch J, Gatell J. Lipodystrophy syndrome in patients with HIV infection. Drug Safety. 2001;24:157–166
21. Negredo E, Higueras C, Adell X, Martinez JC, Martinez E, Puig J, et al. Reconstructive treatment for antiretroviral-associated facial lypoatrophy: A prospective study comparing autologous fat and synthetic substances. AIDS Patient Care and STDs. 2006;20:829–837
    • MEDLINE
    • CrossRef
22. Okie S. Fighting HIV—Lessons from Brazil. The New England Journal of Medicine. 2006;354:1977–1981
    • CrossRef
23. Peterson S, Martins CR, Cofrancesco JR. Lipodystrophy in the patient with HIV: Social, psychosocial, and treatment considerations. Aesthetic Surgery Journal. 2008;28:443–451
24. Power R, Tate HL, McGill SM, Taylor C. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections. 2003;79:137
    • MEDLINE
    • CrossRef
25. Sattler FR. Pathogenesis and treatment of lipodystrophy: What clinicians need to know. Topics in HIV Medicine. 2008;16:127–133